Features Screener Stocks Charts
Sign In Sign Up

Biocon Ltd. Income Statement

NSE:BIOCON | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year BIOCON income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 156.21B 164.70B
Cost of Revenue -48.98B -51.98B
Gross Profit 107.23B 112.72B
Sales, General & Admin -65.59B -68.98B
Operating Income 25.95B 26.88B
Profit Before Tax 16.09B 18.87B
Net Income 12.98B 14.29B
Diluted Shares 1.20B 1.20B
Diluted EPS 8.54 8.46

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025